News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proteome Systems Ltd. Release: US And Australian Biotechs Collaborate To Develop New Semen-Based Non-Invasive Prostate Cancer Test; Prostate Cancer Associated Biomarker Identified By Proteome Systems Just Days Prior To Prostate Cancer Awareness Month



9/6/2006 12:00:37 PM

BOSTON--(BUSINESS WIRE)--Sept. 6, 2006--Just days prior to Prostate Cancer Awareness Month (September 2006) a leading biotech team developing a semen-based prostate cancer test -- designed to improve on the accuracy of the prostate-specific antigen (PSA) test -- has identified a prostate cancer biomarker associated with Human Carcinoma-Antigen (HCA). When present along with HCA, the biomarker will form the basis of a new prostate cancer diagnostic test being developed by Proteome Systems.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES